Tuberculosis (TB) is the main cause of death amongst human immunodeficiency virus
(HIV)-infected individuals worldwide, while 14 million people are estimated to be
dually infected [
[1]
]. In Europe only, the estimated number of deaths from TB in HIV infected patients
exceeded 5100 in 2016. What is more, in EU/EEA countries coinfection was most prevalent
amongst males and those between ages 25–44 years [
[2]
]. A recent study has shown that migration has played a major role in the increasing
numbers of co-infected individuals in Europe, as migrants coming from a low-income
background were shown to be more susceptible to co-infection compared to national
population. The purpose of this article is to highlight the need for a concrete framework
of action towards this growing public health issue.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- HIV infection—associated Tuberculosis: the epidemiology and the response.Clin Infect Dis. 2010; Volume 50: S201-S207https://doi.org/10.1086/651492
- Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles.AIDS (London, England). 2016; 30: 2845-2853https://doi.org/10.1097/QAD.0000000000001252
- Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.PLoS Med. 2011; 8e1000391https://doi.org/10.1371/journal.pmed.1000391
- Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011.Euro Surveill. 2013; 18 (pii=20432)https://doi.org/10.2807/ese.18.12.20432-en
- Diagnosis & treatment of tuberculosis in HIV co-infected patients.Indian J Med Res. 2011; 134: 850-865https://doi.org/10.4103/0971-5916.92630
- Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis.Saudi Med J. 2016; 37: 1076-1081https://doi.org/10.15537/smj.2016.10.14998
- Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.The Int J of Tuberculosis and Lung Dis: The Off J of the Int Union against Tuberculosis and Lung Dis. 2013; 17: 1125-1138https://doi.org/10.5588/ijtld.13.0117
World Health Organization, 2007, Revised BCG vaccination guidelines for children with HIV infection, Accessed 25 May 2019.
World Health Organization, 2010, Antiretroviral therapy for HIV infection in adults and adolescents, Accessed 25 May 2019.
- Treatment of persons living with HIV | treatment | TB | CDC [internet].Cdc.gov([cited 9 July 2019]. Available from:)Date: 2019
- Summary table of HIV/TB co-infection treatment regimens.AIDSFree Project, Arlington, VA2017
World Health Organization, 2006, Management of Tuberculosis and HIV coinfection (Accessed 26 May 2019).
Article info
Publication history
Published online: July 19, 2019
Accepted:
July 13,
2019
Received in revised form:
July 11,
2019
Received:
May 26,
2019
Identification
Copyright
© 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
